Department of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland
University of Zurich, 8006 Zurich, Switzerland
Int J Environ Res Public Health. 2021 May 29;18(11):5846. doi: 10.3390/ijerph18115846.
During the first COVID-19 pandemic outbreak, a new triage concept had to be implemented for patients with retinal diseases having a scheduled appointment at the medical retina clinic. In this study, we aimed to assess patients' confidence in this triage concept and patients' satisfaction regarding the received treatment during the outbreak.
This retrospective study included all patients with a diagnosed retinal disease, triaged into three priority groups based on their condition's urgency during lockdown. After restrictions were eased, a subset of previously triaged patients was interviewed to assess their confidence in the triage and their satisfaction regarding the received treatment during the pandemic.
In total, 743 patients were triaged during the lockdown. Over 80% received an urgent appointment (priority 1). Among all priority 1 patients, over 84% attended their appointment and 77% received an intravitreal injection (IVI), while 7% cancelled their appointment due to COVID-19. In post-lockdown interviews of 254 patients, 90% trusted the emergency regimen and received treatment.
Our triage seemed to be useful in optimizing access to treatment for patients with retinal diseases. An excellent rating of patients' confidence in the triage and satisfaction regarding the received treatment during the first COVID-19 outbreak could be achieved.
在首次 COVID-19 大流行期间，对于在医疗视网膜诊所预约的视网膜疾病患者，必须实施新的分诊概念。在这项研究中，我们旨在评估患者对该分诊概念的信心以及患者对大流行期间所接受治疗的满意度。
这是一项回顾性研究，包括所有被诊断患有视网膜疾病的患者，根据其病情在封锁期间的紧急程度分为三个优先级别。限制放宽后，对先前分诊的一部分患者进行了采访，以评估他们对分诊的信心以及对大流行期间所接受治疗的满意度。
在封锁期间，共有 743 名患者接受了分诊。超过 80%的患者获得了紧急预约（优先级 1）。在所有优先级 1 患者中，超过 84%的患者参加了预约，77%的患者接受了玻璃体内注射（IVI），而 7%的患者因 COVID-19 取消了预约。在大流行后的 254 名患者访谈中，90%的患者信任紧急治疗方案并接受了治疗。
我们的分诊似乎有助于优化视网膜疾病患者的治疗机会。在首次 COVID-19 大流行期间，患者对分诊的信心和对所接受治疗的满意度都得到了很好的评价。
Zotero 插件
